English  |  正體中文  |  简体中文  |  Total items :2816755  
Visitors :  27595327    Online Users :  1371
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"unk m"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-08-13T06:33:29Z Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.; Gautschi O.; Liao W.-Y.; Peters S.;Curioni-Fontecedro A.;Nechushtan H.;Jin-Yuan Shih;Liao W.-Y.;Gautschi O.;Spataro V.;Unk M.;Chih-Hsin Yang J.;Lorence R.M.;Carri?Re P.;Cseh A.;Chang G.-C.; Peters S.; Curioni-Fontecedro A.; Nechushtan H.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:29Z Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.; Gautschi O.; Liao W.-Y.; Peters S.;Curioni-Fontecedro A.;Nechushtan H.;Jin-Yuan Shih;Liao W.-Y.;Gautschi O.;Spataro V.;Unk M.;Chih-Hsin Yang J.;Lorence R.M.;Carri?Re P.;Cseh A.;Chang G.-C.; Peters S.; Curioni-Fontecedro A.; Nechushtan H.; JIN-YUAN SHIH
臺大學術典藏 2020-05-26T09:26:24Z Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation?�Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Chang G.-C.;Cseh A;Carri?re P;Lorence R.M;Chih-Hsin Chih-Hsin Yang;Unk M;Spataro V;Gautschi O;Liao W.-Y;Shih J.-Y;Nechushtan H;Curioni-Fontecedro A;Peters S; Peters S; Curioni-Fontecedro A; Nechushtan H; Shih J.-Y; Liao W.-Y; Gautschi O; Spataro V; Unk M; Chih-Hsin CHIH-HSIN YANG; Lorence R.M; Carrière P; Cseh A; Chang G.-C.
臺大學術典藏 2020-05-26T09:26:24Z Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation?�Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Chang G.-C.;Cseh A;Carri?re P;Lorence R.M;Chih-Hsin Chih-Hsin Yang;Unk M;Spataro V;Gautschi O;Liao W.-Y;Shih J.-Y;Nechushtan H;Curioni-Fontecedro A;Peters S; Peters S; Curioni-Fontecedro A; Nechushtan H; Shih J.-Y; Liao W.-Y; Gautschi O; Spataro V; Unk M; Chih-Hsin CHIH-HSIN YANG; Lorence R.M; Carrière P; Cseh A; Chang G.-C.
臺大學術典藏 2018 Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Peters S.;Curioni-Fontecedro A.;Nechushtan H.;Shih J.-Y.;Wei-Yu Liao;Gautschi O.;Spataro V.;Unk M.;Chih-Hsin Yang J.;Lorence R.M.;Carri?Re P.;Cseh A.;Chang G.-C.; Peters S.; Curioni-Fontecedro A.; Nechushtan H.; Shih J.-Y.; WEI-YU LIAO; Gautschi O.; Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.
臺大學術典藏 2018 Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Peters S.;Curioni-Fontecedro A.;Nechushtan H.;Shih J.-Y.;Wei-Yu Liao;Gautschi O.;Spataro V.;Unk M.;Chih-Hsin Yang J.;Lorence R.M.;Carri?Re P.;Cseh A.;Chang G.-C.; Peters S.; Curioni-Fontecedro A.; Nechushtan H.; Shih J.-Y.; WEI-YU LIAO; Gautschi O.; Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page